Rare diseases by their definition only affect a small proportion of people, which can often be a barrier to innovation. Clinical trials for rare diseases can prove costly and recruitment can be particularly challenging, which has historically led to a lack of interest from pharmaceutical companies.Read more
The UK pharmaceutical industry is passionate about the life sciences and we are always keen to encourage an interest in research. We recognise that the future of success for our industry and, more importantly, the future healthcare for patients in the UK, lies in the next generation.Read more
Last week, researchers, funders and clinicians celebrated International Clinical Trials Day. It’s been 269 years since James Lind performed his now famous first ever clinical trial looking at treatments for scurvy. But fast forward almost 270 years and clinical trials are more complex than ever before.Read more
The Association of the British Pharmaceutical Industry (ABPI) has highlighted how patients in the UK would miss out on ground-breaking clinical trials by voting to leave the EU.Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.